» Articles » PMID: 23921617

Anal and Penile High-risk Human Papillomavirus Prevalence in HIV-negative and HIV-infected MSM

Overview
Journal AIDS
Date 2013 Aug 8
PMID 23921617
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Anal and penile high-risk human papillomavirus (HPV) infection is associated with anogenital cancer, which is especially common in HIV-infected MSM. We assessed HPV prevalence and determinants in MSM.

Design: Analysis of baseline data from a prospective cohort study.

Methods: MSM aged 18 years or older were recruited in Amsterdam, the Netherlands. Participants completed risk-factor questionnaires. HPV DNA was analyzed in anal and penile shaft self-swabs and genotyped using a sensitive PCR and reverse line blot assay (SPF10-PCR-DEIA-LiPA25-system). Multivariable logistic regression analyses were performed to assess determinants of high-risk HPV infection.

Results: MSM (n = 778) were recruited in 2010-2011, of whom 317 (41%) were HIV-infected. Prevalence of anal high-risk HPV infection was 45% in HIV-negative versus 65% in HIV-infected MSM (P <0.001). HPV-16 was the most frequently detected type and was more common in HIV-infected MSM (13% in HIV-negative and 22% in HIV-infected MSM; P = 0.001). Prevalence of penile high-risk HPV infection was 16% in HIV-negative and 32% in HIV-infected MSM (P <0.001). In multivariable analyses, HIV infection remained associated with anal [adjusted odds ratio (aOR) 2.2; 1.8-2.7] and penile (aOR 2.0; 1.4-2.9) high-risk HPV infection. Higher number of lifetime male sex partners was significantly associated with anal and penile high-risk HPV in HIV-negative, but not HIV-infected MSM. Receptive anal intercourse was associated with anal high-risk HPV in HIV-infected MSM.

Conclusion: Anal and penile high-risk HPV infections are very common in MSM. HIV infection is a strong and independent determinant for anal and penile high-risk HPV infection. Determinants for HPV infection appear to differ between HIV-negative and HIV-infected MSM.

Citing Articles

A clinical overview of people living with HIV and genitourinary cancer care.

Suk-Ouichai C, Coghill A, Schabath M, Sanchez J, Chahoud J, Necchi A Nat Rev Urol. 2024; 21(6):373-383.

PMID: 38238527 DOI: 10.1038/s41585-023-00846-8.


Evaluation of the validity of the HPV viral load compared to conventional techniques for the detection of high-grade anal intraepithelial lesions in men with HIV who have sex with men.

Diez-Martinez M, Perpina-Galvan J, Ferri J, Ventero M, Portilla J, Cabanero-Martinez M PeerJ. 2023; 11:e15878.

PMID: 37637161 PMC: 10460151. DOI: 10.7717/peerj.15878.


Prevalence and factors associated with anogenital warts among sexual and gender minorities attending a trusted community health center in Lagos, Nigeria.

Adebajo S, Nowak R, Adebiyi R, Shoyemi E, Ekeh C, Ramadhani H PLOS Glob Public Health. 2023; 2(11):e0001215.

PMID: 36962635 PMC: 10021808. DOI: 10.1371/journal.pgph.0001215.


Factors that Predict HPV Vaccination Behavior Among Young Men-Who-Have-Sex-with-Men in the Greater Philadelphia Region.

Mann-Barnes T, Bhimla A, Coronado M, Lin T, Duro-Aina A, Park H J Racial Ethn Health Disparities. 2022; 10(5):2167-2174.

PMID: 36036840 PMC: 9422934. DOI: 10.1007/s40615-022-01396-2.


Predictors of Anal High-Risk HPV Infection Across Time in a Cohort of Young Adult Sexual Minority Men and Transgender Women in New York City, 2015-2020.

LoSchiavo C, DAvanzo P, Emmert C, Krause K, Ompad D, Kapadia F Am J Mens Health. 2022; 16(4):15579883221119084.

PMID: 36005272 PMC: 9421230. DOI: 10.1177/15579883221119084.